Therapy and Tech Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, Irvine
About this trial
The investigators want to test if gen AI can support therapy by recruiting patients already in therapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18+
US Resident
English-speaking
Self-report having been treated for or diagnosed with generalized anxiety disorder or major depressive disorder by a licensed provider (e.g., MD, DO, LPCC, LCSW, LMFT) in the past 12 months
Disqualifiers
Ever diagnosed with schizophrenia, schizoaffective disorder, bipolar disorder, or hospitalized for suicidality
Trial design
Design model
Parallel
Treatments tested in this trial
Chatbot Therapy
BehavioralThis group will be asked to use an AI chatbot like chatgpt as an adjunct to their regular therapy
Treatment groups
204 Participants
are divided into 2 treatment groupsGroup A: Chatbot Therapy GroupExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Generalized Anxiety Disorder (GAD-7)
Questions about symptoms of generalized anxiety disorder. Scale is 0-21. Higher scores is a worse outcome.
Time frame
Baseline, 4-week follow-up, 8-week follow-up2
Patient Health Questionnaire (PHQ-9)
Questions about symptoms of depression. Scale is 0-27. Higher score is a worse outcome.
Time frame
Baseline, 4-week follow-up, 8-week follow-upLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, Irvine
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: